MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAF(V600E) Mutation Detected in Circulating-Free DNA

The BRAF(V600E) mutation is associated with melanoma development and its detection in circulating-free DNA cannot be observed in all melanoma patients harboring this mutation in tumor specimens. Beside the circulating-free DNA BRAF(V600E) mutation, other markers of therapeutic response should be ide...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pharmacol
Auteurs principaux: Salemi, Rossella, Falzone, Luca, Madonna, Gabriele, Polesel, Jerry, Cinà, Diana, Mallardo, Domenico, Ascierto, Paolo A., Libra, Massimo, Candido, Saverio
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6102751/
https://ncbi.nlm.nih.gov/pubmed/30154717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00856
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires